ANUHPHR
Anuh Pharma Limited
Each stock's 10,000-path forecast, rendered as light.
Anuh Pharma Limited (ANUHPHR) Stock Analysis & Case Study
What the numbers say about ANUHPHR, and the method behind each one.
Anuh Pharma Limited (ANUHPHR) trades at ₹76,on the numbers it worth a closer look, a Downstox Snapshot Score of 59/100.
On the numbers, Anuh Pharma Limited (ANUHPHR) worth a closer look, a Downstox Snapshot Score of 59/100, weighing fairly valued at 17.2× earnings, ROE of 10.7%, a 53% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
ANUHPHR fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How ANUHPHR ranks against the 3,124 companies in our screener
- ANUHPHR's market cap of 758 Cr ranks in the 47th percentile of the 3,124 NSE companies in our screener, as of 18 Aug 2026.
- ANUHPHR's book value of ₹35 ranks in the 27th percentile of the 3,124 NSE companies in our screener, as of 18 Aug 2026.
- ANUHPHR's promoter holding of 71.8% ranks in the 77th percentile of the 3,124 NSE companies in our screener, as of 18 Aug 2026.
- ANUHPHR's 3-year profit (PAT) growth of 3.0% ranks in the 31st percentile of the 3,124 NSE companies in our screener, as of 18 Aug 2026.
- ANUHPHR's 3-year revenue growth of 14.0% ranks in the 57th percentile of the 3,124 NSE companies in our screener, as of 18 Aug 2026.
We do not hold a debt-to-equity ratio figure for ANUHPHR, as of 18 Aug 2026, so it is not ranked here.
Is ANUHPHR overvalued? ANUHPHR P/E vs peers
ANUHPHR trades at 17.2× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
ANUHPHR share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.8y of ANUHPHR history (5%/yr drift, 37%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| ANUHPHR 2027 | ₹48 | ₹78 | ₹128 | +3% |
| ANUHPHR 2028 | ₹41 | ₹81 | ₹161 | +7% |
| ANUHPHR 2029 | ₹37 | ₹84 | ₹191 | +10% |
| ANUHPHR 2030 | ₹34 | ₹86 | ₹221 | +14% |
| ANUHPHR 2031 | ₹31 | ₹89 | ₹259 | +17% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability ANUHPHR goes up, or doubles?
The bull case for ANUHPHR
- ANUHPHR's P/E of 17.2x is lower than 63% of the 3,124 NSE companies in our screener, as of 18 Aug 2026.
- ANUHPHR's Piotroski F-Score of 6/8 ranks in the 86th percentile of the 3,124 NSE companies in our screener, as of 18 Aug 2026.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹191.
The bear case & risks
- ANUHPHR's return on equity of 10.7% ranks in the 52nd percentile of the 3,124 NSE companies in our screener, as of 18 Aug 2026.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹37.
ANUHPHR volatility & expected range, how bumpy is the ride?
Over the last 9.8 years ANUHPHR compounded at 5%/year with annualized volatility of 37%. That volatility implies a 1-year 80% range of ₹48-₹128, the honest backbone behind any single price target.
ANUHPHR price forecast, the full 60-month probability fan
ANUHPHR price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds ANUHPHR hits common targets within the simulated horizon?
Full multi-horizon detail on the ANUHPHR price target & forecast page.
ANUHPHR Piotroski F-Score: 6/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. ANUHPHR scores 6/8, financially strong this cycle.
ANUHPHR MTF margin & leverage across 2 brokers
Margin Trading Facility lets you buy ANUHPHR with part of the capital. Lower margin % = higher leverage. Rates compared across 2 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Kotak Neo | 100.00% | 1.0× |
| Share IndiaCHEAPEST | 31.99% | 3.1× |
Compare every broker on the ANUHPHR MTF page.
About Anuh Pharma Limited: sector, index & market-cap context
Anuh Pharma Limited (ANUHPHR) is a small-cap NSE-listed company, with a market capitalisation of ₹758 Cr. See more stocks on our screener.
How the ANUHPHR Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Anuh Pharma Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
ANUHPHR analysis, FAQs
Is Anuh Pharma Limited (ANUHPHR) a good buy?
On the numbers, Anuh Pharma Limited (ANUHPHR) worth a closer look, a Downstox Snapshot Score of 59/100, weighing fairly valued at 17.2× earnings, ROE of 10.7%, a 53% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is ANUHPHR overvalued or undervalued?
ANUHPHR trades at 17.2× earnings, fairly valued versus the ~22× long-run Nifty average.
What is the ANUHPHR share price target for 2031?
ANUHPHR's probability-weighted 2031 median target is ₹89, with an 80% range of ₹31-₹259 (10,000-path Monte-Carlo).
What is the probability ANUHPHR doubles in 5 years?
The modelled probability of ANUHPHR reaching ₹152 (2×) within 5 years is 26%.
What is the bull case for ANUHPHR?
ANUHPHR's P/E of 17.2x is lower than 63% of the 3,124 NSE companies in our screener, as of 18 Aug 2026. ANUHPHR's Piotroski F-Score of 6/8 ranks in the 86th percentile of the 3,124 NSE companies in our screener, as of 18 Aug 2026.
What are the risks in ANUHPHR?
ANUHPHR's return on equity of 10.7% ranks in the 52nd percentile of the 3,124 NSE companies in our screener, as of 18 Aug 2026.
More on ANUHPHR
For information and education only. Downstox is a data and analytics platform, not a SEBI-registered Research Analyst or Investment Adviser. Nothing here is investment advice or a recommendation to buy, sell or hold any security. Any scores, ranks, targets or scenarios are model estimates shown with their method, not forecasts or assured outcomes. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing.